SYRESpyre Therapeutics Inc. Common Stock
106.49USD-2.23%Mkt Cap: 9.25B $P/E: —3d ago
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humani…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap9.25B $
Enterprise Value8.51B $
Revenue (TTM)—
Gross Profit-215.80M $
Net Income (TTM)-155.20M $
Revenue/Share—
Last Price106.49 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees125
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-31.30
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B9.94
EPS (TTM)-1.90
EPS (Forward)-3.44
52W Range
14.5196% of range110.18
52W High110.18 USD
52W Low14.51 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-21.70%
ROA-19.95%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-169.25M $
CapEx (TTM)—
FCF Margin—
FCF Yield-0.96%
Net Debt-1.15B $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio18.53
Quick Ratio18.23
Book Value/Sh10.84 USD
Cash/Share12.99 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateSep 8, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)124.71 USD
Upside (mean)+17.1%
Target Range97.00 USD – 140.00 USD
$97.00+17.1% to mean$140.00
# Analysts14
Ownership
Shares Out.86.84M
Float82.15M
Insiders5.74%
Institutions110.68%
Short Interest
Short Ratio10.6d
Short % Float14.73%
Short % Out.13.77%
Shares Short12.14M
Short (prev mo.)13.64M
Technical
SMA 5096.33 (+10.5%)
SMA 20058.06 (+83.4%)
Beta3.03
S&P 52W Chg18.16%
Avg Vol (30d)910.14K
Avg Vol (10d)798.30K
Technical Indicators
RSI (14)58.3
MACD3.1341
MACD Signal3.2117
MACD Hist.-0.0776
BB Upper109.09 USD
BB Middle102.50 USD
BB Lower95.92 USD
BB Width12.85%
ATR (14)5.420 USD
Vol Ratio (20d)1.17x